JPMorgan Downgrades Boston Scientific (BSX) Amid Pipeline Delays and Lower Guidance

gurufocus.com · 2026-10-28

On October 28, 2026, JPMorgan downgraded Boston Scientific Corp (NYSE: BSX) from an Overweight rating to Neutral and cut its price target from $56 to $46. This

Read the full story at gurufocus.com →